Soul Patts/Genesis Bump NBIO For Monash IVF (MVF AU)
Back on the 24th November Monash IVF (MVF AU), a fertility provider, announced, and summarily rejected, a A$0.80/share non-binding indicative Offer from Soul Patts (SOL AU) & Genesis Capital.
Soul Patts & Genesis have returned to the well with a A$0.90/share NBIO (”best & final”). The indicative terms are a ~47% premium to undisturbed and 34% to last close.
Genesis/Soul Patts collectively hold 19.6% in MVF. Monash should engage.
Monash is illiquid - look away now if this is not your thing.
The Trade:
Trading ~17% adrift of the indicative terms.
Monash should engage.
I’d be picking up shares here, and on any weakness.
Keep reading with a 7-day free trial
Subscribe to Aussie/Kiwi M&A/Events to keep reading this post and get 7 days of free access to the full post archives.

